Clinical Trial Update: Gabapentin for Abstinence Initiation in Alcohol Dependence [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 clinical trial update for gabapentin in initiating abstinence among individuals with alcohol dependence; study completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Dependence

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Alcohol Dependence | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-07-18